(Q59565353)
Statements
TP53 genomics predict higher clinical and pathologic tumor response in operable early-stage breast cancer treated with docetaxel-capecitabine ± trastuzumab (English)
Stefan Glück
Melanie Royce
Eli Avisar
Lin Wu
Jeffrey S Ross
Edward F McKenna